Who owns VIVOS THERAPEUTICS INC?
- Ticker: VVOS
- CUSIP Number: 92859e207
Tip: Access positions for across all investors
Analyze quarterly positions in Vivos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vivos Therapeutics stock
Who bought or sold VIVOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 1.1M | $1.3M | 100% | Mar 2026 |
|
| Geode Capital Management | 96k | $113k | 70% | Mar 2026 |
|
| Commonwealth Equity Services | 43k | $50k | 5% | Mar 2026 |
|
| IHT Wealth Management | 41k | $49k | 100% | Mar 2026 |
|
| National Asset Management | 38k | $19k | 0% | Jun 2026 |
|
| Centurion Wealth Management | 36k | $16k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 31k | $36k | 100% | Mar 2026 |
|
| BlackRock | 28k | $33k | 0% | Mar 2026 |
|
| XTX Topco | 25k | $30k | 100% | Mar 2026 |
|
| State Street Corporation | 25k | $29k | 0% | Mar 2026 |
|
| Sequoia Financial Advisors | 24k | $11k | 0% | Jun 2026 |
|
| Acorn Wealth Advisors | 15k | $17k | 0% | Mar 2026 |
|
| Northern Trust | 13k | $15k | 0% | Mar 2026 |
|
| UBS Group | 11k | $13k | -13% | Mar 2026 |
|
| Tower Research Capital | 7.4k | $8.7k | 149% | Mar 2026 |
|
| Advisor Group Holdings | 1.1k | $1.3k | 0% | Mar 2026 |
|
| Signature | 547.00 | $248.994400 | 0% | Jun 2026 |
|
| Ronald Blue Trust | 160.00 | $188.992000 | 0% | Mar 2026 |
|
| Kozak & Associates | 49.00 | $24.000200 | 0% | Jun 2026 |
|
| Morgan Stanley | 7.00 | $8.000300 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 4.00 | $0 | 100% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 3.00 | $3.999900 | 100% | Mar 2026 |
|
| Citigroup | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Vivos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Dec 2025 | 116k | $235k |